It has long been postulated that the fetal immune system develops in a sterile environment, without antigen exposure, and therefore that it is essentially immature. Immune immaturity has also been considered to be the main reason why newborns and infants are generally more susceptible to infections. However, more recent work has started to challenge these assumptions, not only the sterility of the placental environment, but also the lack of functionality of the human fetal immune system. Furthermore, the growing realization that in utero exposure of the immune system may have a lifelong impact, notably influencing many noncommunicable diseases involving immune dysfunction (asthma and autoimmunity), is generating a push toward gaining a better understanding of the ontogeny and the functionality of the fetal immune system, not only under homeostatic conditions, but also in the context of infection and inflammation. However, as development of the immune system, particularly of the adaptive immune system, is markedly different in humans and small rodents, there is still a paucity of data on this topic. In this issue, Frascoli et al. bring us a step closer to identifying and understanding the functional capabilities of human fetal T cells (1) .
Functional innate-like lymphocytes, natural killer cells,  T cells, and mucosa-associated invariant T cells are all found in healthy human fetuses. Maturation of human fetal T cells also occurs in utero, with T cell zones appearing in the spleen as early as 18 weeks of gestation. This is in marked contrast to murine models, in which T cells emigrate from the thymus after birth. Although most of these cells are naïve, CD4 + T cells with a memory phenotype are found in the human fetal intestine, spleen, and skin [reviewed in (2) ]. Further demonstrating that fetal T cells can be fully activated, it has long been known that infants exposed in utero to viruses, such as HIV or cytomegalovirus (CMV), are born with antigenspecific CD4 + T cells and CD8 + T cells, even when the infants themselves are not infected. Similarly, antigen-specific T cells are detectable at birth in many infants born to mothers harboring a variety of parasitic infections. It has been proposed that one of the major influences on fetal T cells is maternal microchimerism. Substantial numbers of maternal cells cross the placenta by incompletely defined passive or active mechanisms and are found in fetal lymph nodes. In seminal studies, Mold et al. showed that human fetal CD4 + T cells preferentially differentiate into regulatory T cells (T regs ) when stimulated in vitro, and that this bias develops in response to cells bearing non-inherited maternal allo-antigens (NIMA) (3). These fetal T regs are thought to prevent maternal-fetal conflict, and this control persists after birth, as T regs in adolescents continue to be more efficient at dampening responses to maternal allo-antigens than to paternal antigens (3) .
Another factor that probably shapes the fetal immune system is its exposure to microbial products and inflammatory mediators. Indeed, recent studies detected bacterial DNA sequences in the amniotic cavity more frequently than presumed historically, even in healthy pregnancies, although detection of background DNA could have been a confounding factor in some of these studies. Molecular evidence of microbial invasion of the amniotic cavity was strongly associated with spontaneous preterm birth, and intracellular bacteria were detected in the placental basal plate in about half of the women who delivered spontaneously before 28 weeks [reviewed in (4) ]. This microbial signature correlated with signs of placental inflammation, or chorioamnionitis. Notably, the 16S rDNA copy number in the amniotic fluid was found to be higher in women with severe chorioamnionitis than in those with mild or no chorioamnionitis (5) . These data thus corroborate previous studies where chorioamnionitis was diagnosed histologically in ~25% of late preterm and >50% of early preterm births, with or without rupture of membranes [reviewed in (6) ]. Importantly, chorioamnionitis, particularly in very preterm births, is associated with neonatal diseases such as cerebral palsy, necrotizing enterocolitis, and bronchopulmonary dysplasia, as well as longer-term deleterious outcomes such as wheezing and asthma [reviewed in (6) ]. Proinflammatory cytokines are high, not only in the amniotic fluid, but also in the cord blood of infants exposed to severe chorioamnionitis, demonstrating that the fetal immune system has been exposed, and has reacted, to either inflammatory mediators or bacterial products, or most likely both.
The new study by Frascoli et al.
(1) suggests that we should consider how the two influences of microchimerism and infection/ inflammation might intersect in the context of inflammation-induced preterm birth. In this study, the authors analyzed immune profiles in the cord blood of term and preterm newborns, and their mothers. Signs of immune activation were obvious in the cord blood of many preterm babies, many of whom were exposed to chorioamnionitis. A notable find ing of this paper is that maternal microchimerism was more profound in these preterm babies, thus providing additional evidence of an inflammation-driven increase in maternal microchimerism. The same authors reported earlier that fetuses with severe congenital diaphragmatic hernia, who exhibited high inflammatory cytokines in cord blood, also showed increased maternal microchimerism (7). A similar increase was also described in babies exposed to placental malaria (8) . Interestingly, the latter study showed that both malaria infection and inflammation contributed to this enhanced transfer of maternal cells.
Even more strikingly, Frascoli et al. describe the presence of a subset of central memory CD4 + T cells with the characteristics of T H 1 cells in the blood of preterm babies, whereas this population was almost undetectable in term babies (1) . Importantly, they show that fetal CD4 + T cells from these preterm babies proliferate more vigorously in response to maternal antigens than those from term babies. Such activation appeared to be specific, as they did not exhibit a stronger reactivity to third-party allo-antigens. This study thus indicates that the human fetal immune system is influenced by maternal antigens, but the outcome is not always tolerogenic, in contrast to the model suggested by Mold et al. (3) . The mechanisms underlying these differences were not investigated in this paper, but the fact that preterm babies' dendritic cells exhibited an activated phenotype may give us a clue. Indeed, murine fetal/neonatal T cells were shown long ago to be fully competent to respond to mature adult dendritic cells (9) . Thus, the model indicated by these findings is that, in the context of in utero inflammation, the fetal immune system is exposed to more maternal allo-antigens in an inflammatory context, and this double-hit results in the activation of effector cells, not classic T regs (Fig. 1 ). It will be important to directly test this hypothesis, showing that inflammationtriggered maturation of fetal dendritic cells leads to allo-specific fetal T cell activation. It would also be important to determine whether inflammation induces NIMA-specific inflammatory T regs that express not only FoxP3 and other molecules associated with a T reg phenotype, but also "effector" transcription factors such as T-bet or RAR-related orphan receptor C (RORC). Showing that these NIMA-specific inflammatory T regs can pro duce effector cytokines upon stimulation also will be key. Indeed, from investigating the effect of severe chorioamnionitis on fetal T cells, we have shown the emergence of these inflammatory T regs in the fetal spleen, and less abundantly in the blood (10) . Although the authors did not find differences in the numbers of T regs , they did not investigate the functional characteristics of these cells in detail.
Another intriguing finding of this study is that in vitro contact of T cells from preterm infants with a myometrial cell line stimulated uterine myometrial contractility through enhanced IFN- and TNF- production. In a murine model, adoptive transfer of IFN--competent and TNF--competent T cells provoked fetal resorption. The authors thus postulate that activated fetal T cells could play an active role in preterm labor through cytokineinduced induction of uterine con tractions, although whether fetal T cells produce enough cytokines to act on a dis tal site such as the uterus remains to be proven.
The Frascoli et al. study (1) has several limitations, one being that only peripheral immune cells, both maternal and cord blood cells, were analyzed, thus providing only a partial view of the activation processes. This is a caveat inherent to the study of the human neonatal immune system, as collecting biological samples other than blood is even less feasible in this population than it is in other human subjects. Additionally, it is not known how long this activation persists after birth. These important points will likely be more easily addressed in animal models with an ontogeny of the immune system close to that of humans, such as non-human primates or pigs. Another limitation is that women who go into preterm labor are a heterogeneous group, as demonstrated by the large variability in the concentration of inflammatory cytokines measured in the cord blood in this study and others. Mechanisms explaining why more robust maternal microchimerism occurs in the context of inflam mation also need to be elucidated, notably because the reverse traffic (fetal cells into the mother) did not appear to be affected in this study. This suggests that at least some of the signals that con trol cellular movements across the placental barrier are selective and can be affected by inflammation. Overall, the Frascoli et al. study supports the growing concept that immune dysregulation can begin in and T reg , combined with intrinsic DC immaturity. When exposed to maternal microchimerism, these fetal DCs induce a predominantly T reg response against non-inherited maternal allo-antigens (NIMA). (Right) In contrast, in the context of inflammation-induced prematurity, maternal microchimerism is more pronounced. In addition, fetal DCs are activated by microbial products and pro-inflammatory cytokines that are present in the amniotic fluid and the fetal circulation. These fetal DCs direct the activation of NIMA-specific effector fetal T cells, which produce pro-labor effector cytokines, such as IFN- and TNF- (1).
utero, and it further emphasizes how important it is to precisely understand the interplay between in flam ma tion, maternal microchimerism, and the ac tivation of fetal immune responses.
